At the time of writing, Thermo Fisher Scientific Inc [TMO] stock is trading at $565.24, up 0.06%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The TMO shares have gain 1.36% over the last week, with a monthly amount glided 3.91%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Thermo Fisher Scientific Inc [NYSE: TMO] stock has seen the most recent analyst activity on September 11, 2025, when Barclays upgraded its rating to a Overweight but kept the price target unchanged to $550 for it. On July 24, 2025, downgrade downgraded it’s rating to Hold but maintained its price target of $510 on the stock. Scotiabank upgraded its rating to a Sector Outperform but stick to its price target of $590 on July 11, 2025. UBS downgraded its rating to a Neutral but $460 remained the price target by the analyst firm on July 09, 2025. Bernstein upgraded its rating to Outperform for this stock on January 10, 2025, but kept the price target unchanged to $630. In a note dated December 23, 2024, Scotiabank initiated an Sector Perform rating.
For the past year, the stock price of Thermo Fisher Scientific Inc fluctuated between $385.46 and $610.97. Currently, Wall Street analysts expect the stock to reach $599.57 within the next 12 months. Thermo Fisher Scientific Inc [NYSE: TMO] shares were valued at $565.24 at the most recent close of the market. An investor can expect a potential return of 6.07% based on the average TMO price forecast.
Analyzing the TMO fundamentals
According to Thermo Fisher Scientific Inc [NYSE:TMO], the company’s sales were 43.74B for trailing twelve months, which represents an 4.94% jump. Gross Profit Margin for this corporation currently stands at 0.4% with Operating Profit Margin at 0.18%, Pretax Profit Margin comes in at 0.16%, and Net Profit Margin reading is 0.15%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.13 and Total Capital is 0.09. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.7.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 558.39 points at the first support level, and at 551.55 for the second support level. However, for the 1st resistance point, the stock is sitting at 570.69, and for the 2nd resistance point, it is at 576.15.
Ratios To Look Out For
It is important to note that Thermo Fisher Scientific Inc [NYSE:TMO] has a current ratio of 1.50. As well, the Quick Ratio is 1.11, while the Cash Ratio is 0.13. Considering the valuation of this stock, the price to sales ratio is 4.86, the price to book ratio is 4.16 and price to earnings (TTM) ratio is 32.66.
Transactions by insiders
Recent insider trading involved Pettiti Gianluca, Executive Vice President, that happened on Oct 24 ’25 when 400.0 shares were sold. Chairman & CEO, CASPER MARC N completed a deal on Oct 24 ’25 to sell 17104.0 shares. Meanwhile, Chairman & CEO CASPER MARC N sold 7250.0 shares on Oct 27 ’25.
